Haokao Gao Selected Research

Hyperuricemia

1/2022

Percutaneous coronary intervention improves quality of life of patients with chronic total occlusion and low estimated glomerular filtration rate.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Haokao Gao Research Topics

Disease

17	Neoplasms (Cancer) 02/2013 - 01/2011
4	Reperfusion Injury 01/2014 - 08/2009
4	Breast Neoplasms (Breast Cancer) 01/2013 - 04/2011
3	Cardiovascular Diseases (Cardiovascular Disease) 12/2022 - 04/2012
3	Insulinoma 03/2012 - 10/2011
2	Hemorrhage 01/2022 - 01/2022
2	Myocardial Ischemia (Ischemic Heart Diseases) 12/2012 - 01/2012
2	Prostatic Neoplasms (Prostate Cancer) 10/2012 - 01/2011
2	Pancreatic Neoplasms (Pancreatic Cancer) 07/2012 - 03/2012
2	Myocardial Infarction 04/2012 - 01/2012
2	Infarction (Infarctions) 01/2012 - 08/2009
1	Hypertension (High Blood Pressure) 01/2022
1	Acute Kidney Injury (Acute Renal Failure) 01/2022
1	Hyperuricemia 01/2022
1	Stroke (Strokes) 01/2022
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022
1	Hematoma 01/2022
1	Hypoxia (Hypoxemia) 01/2021
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2021
1	Chronic Limb-Threatening Ischemia 12/2019
1	Ischemia 09/2015
1	Myocardial Reperfusion Injury 11/2014
1	Acute Coronary Syndrome 11/2014
1	Glioblastoma (Glioblastoma Multiforme) 02/2013
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2013
1	Squamous Cell Neoplasms (Squamous Cell Cancer) 12/2012
1	Pathologic Neovascularization 01/2012
1	Heart Diseases (Heart Disease) 01/2012
1	Cardiac Arrhythmias (Arrythmia) 01/2012
1	Melanoma (Melanoma, Malignant) 10/2011
1	Head and Neck Neoplasms (Head and Neck Cancer) 10/2011
1	Bacterial Infections (Bacterial Infection) 02/2010
1	Atherosclerosis 02/2010

Drug/Important Bio-Agent (IBA)

4	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2021 - 10/2011
4	Peptides (Polypeptides)IBA 12/2012 - 01/2011
3	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 04/2011
2	omega-Chloroacetophenone (Mace)IBA 12/2022 - 01/2022
2	Silicon Dioxide (Silica)FDA LinkGeneric 02/2013 - 06/2012
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2013 - 12/2012
2	liposomal doxorubicin (Doxil)FDA Link 01/2013 - 10/2011
2	Proteins (Proteins, Gene)FDA Link 12/2012 - 01/2012
2	IntegrinsIBA 12/2012 - 04/2012
2	AntibodiesIBA 07/2012 - 02/2010
2	AntigensIBA 07/2012 - 10/2011
2	Exenatide (Byetta)FDA Link 03/2012 - 01/2012
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022
1	TicagrelorIBA 01/2022
1	Hemoglobins (Hemoglobin)IBA 01/2022
1	Clopidogrel (Plavix)FDA Link 01/2022
1	ArrestinIBA 01/2021
1	MitoTEMPOIBA 12/2019
1	Small Interfering RNA (siRNA)IBA 09/2015
1	Complementary DNA (cDNA)IBA 09/2015
1	Rosuvastatin Calcium (Crestor)FDA Link 11/2014
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 11/2014
1	AnionsIBA 01/2014
1	Superoxides (Superoxide)IBA 01/2014
1	Superoxide DismutaseIBA 01/2014
1	Caspase 3 (Caspase-3)IBA 01/2013
1	Firefly LuciferasesIBA 01/2013
1	Peptide Receptors (Peptide Receptor)IBA 12/2012
1	Annexin A5IBA 12/2012
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2012
1	LigandsIBA 10/2012
1	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 07/2012
1	Cell Adhesion MoleculesIBA 07/2012
1	Single-Domain AntibodiesIBA 07/2012
1	alfatide IIIBA 04/2012
1	Glucagon-Like Peptide-1 ReceptorIBA 01/2012
1	Fingolimod Hydrochloride (FTY720)FDA Link 01/2012
1	antibiotic K 4 (K 4)IBA 01/2012
1	1,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA 01/2012
1	LuteolinIBA 01/2012
1	Human Serum Albumin FDA LinkGeneric 10/2011
1	anthrax toxin (anthrax lethal factor)IBA 10/2011
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 07/2011
1	ZD 4190IBA 07/2011
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 07/2011
1	fluoromisonidazoleIBA 04/2011
1	Bombesin Receptors (Bombesin Receptor)IBA 01/2011
1	BombesinIBA 01/2011
1	oxidized low density lipoproteinIBA 02/2010
1	Immunoglobulin M (IgM)IBA 02/2010
1	2- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- oneIBA 08/2009
1	Glycogen Synthase (Synthase I)IBA 08/2009
1	Phosphatidylinositols (Phosphatidylinositol)IBA 08/2009
1	Glycogen Synthase Kinase 3 betaIBA 08/2009

Therapy/Procedure

8	Therapeutics 01/2022 - 04/2011
3	Percutaneous Coronary Intervention 01/2022 - 11/2014
3	Aftercare (After-Treatment) 01/2013 - 07/2011
1	Ligation 09/2015
1	Drug Therapy (Chemotherapy) 01/2013
1	Intravenous Injections 10/2011
1	Oral Administration 07/2011